BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19542955)

  • 1. Suppression of F-18 fluorodeoxyglucose uptake in benign uterine leiomyomas with danazol.
    Tripathi M; Srivastava M; Garg G; Jaimini A; Singh N; Souza MD; Kaur P; Sharma R; Mandal A
    Clin Nucl Med; 2009 Jul; 34(7):452-5. PubMed ID: 19542955
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose uptake in uterine leiomyomas in healthy women.
    Tsukada H; Murakami M; Shida M; Kikuchi K; Watanabe M; Yasuda S; Suzuki Y
    Clin Imaging; 2009; 33(6):462-7. PubMed ID: 19857807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign uterine uptake of FDG: a case report and review of literature.
    Vriens D; de Geus-Oei LF; Flucke UE; van der Kogel AJ; Oyen WJ; Vierhout ME; van der Meer JW
    Neth J Med; 2010 Sep; 68(9):379-80. PubMed ID: 20876921
    [No Abstract]   [Full Text] [Related]  

  • 4. F-18 fluorodeoxyglucose uptake in leiomyomatous uterus.
    Shida M; Murakami M; Tsukada H; Ishiguro Y; Kikuchi K; Yamashita E; Kajiwara H; Yasuda M; Ide M
    Int J Gynecol Cancer; 2007; 17(1):285-90. PubMed ID: 17291269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG uptake in a huge uterine myoma.
    Kao CH
    Clin Nucl Med; 2003 Mar; 28(3):249. PubMed ID: 12592145
    [No Abstract]   [Full Text] [Related]  

  • 6. Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography.
    Ak I; Ozalp S; Yalçin OT; Zor E; Vardareli E
    Nucl Med Commun; 2004 Sep; 25(9):941-5. PubMed ID: 15319600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intense FDG uptake of metastatic clear cell carcinoma from the ovary in a uterine leiomyoma.
    Cherng SC; Liou CH; Fan YM; Yuan YN; Chiu CS
    Clin Nucl Med; 2006 Jul; 31(7):429-31. PubMed ID: 16785818
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen-dependent variations in 18F-fluorodeoxyglucose uptake in uterine leiomyomas.
    Lerman H; Bar-On S; Helpman L; Even-Sapir E; Grisaru D
    Int J Gynecol Cancer; 2012 Sep; 22(7):1187-91. PubMed ID: 22801027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and characteristics of uterine leiomyomas with FDG uptake.
    Nishizawa S; Inubushi M; Kido A; Miyagawa M; Inoue T; Shinohara K; Kajihara M
    Ann Nucl Med; 2008 Nov; 22(9):803-10. PubMed ID: 19039559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of fluorodeoxyglucose uptake by leiomyomas in relation to histopathologic subtype and the menstrual state.
    Yoshida Y; Tsujikawa T; Kurokawa T; Tsuji T; Imamura Y; Fujibayashi Y; Okazawa H; Kotsuji F
    J Comput Assist Tomogr; 2009; 33(6):877-81. PubMed ID: 19940654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of uterine fibromyomas with danazol.
    De Leo V; la Marca A; Morgante G
    Gynecol Obstet Invest; 1999; 47(4):258-62. PubMed ID: 10352389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin.
    Ueki M; Okamoto Y; Tsurunaga T; Seiki Y; Ueda M; Sugimoto O
    J Obstet Gynaecol (Tokyo 1995); 1995 Feb; 21(1):1-7. PubMed ID: 8591104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effect of danazol therapy in women with uterine leiomyomata.
    La Marca A; Musacchio MC; Morgante G; Petraglia F; De Leo V
    Fertil Steril; 2003 May; 79(5):1240-2. PubMed ID: 12738528
    [No Abstract]   [Full Text] [Related]  

  • 15. Case of uterine leiomyoma showing fludeoxyglucose uptake on F-18 fludeoxyglucose positron emission tomography/computed tomography.
    Park JH; Han JY; Hyun IY; Lee BI; Moon YS
    J Obstet Gynaecol Res; 2010 Dec; 36(6):1261-4. PubMed ID: 21083837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Ma Y; Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Nov; 37(11):1206-11. PubMed ID: 27281358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CT.
    Nunes RF; Queiroz MA; Buchpiguel CA; Carvalho FM; Carvalho JP
    Clin Nucl Med; 2019 Jun; 44(6):e413-e414. PubMed ID: 30985441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography and uterine leiomyomas.
    Lee WL; Yuan CC; Wang PH
    Gynecol Oncol; 2007 Dec; 107(3):593-4; author reply 594-5. PubMed ID: 17826823
    [No Abstract]   [Full Text] [Related]  

  • 19. F-18 FDG PET/CT findings of a case of complete hydatidiform mole.
    Suga K; Nawata S; Kawakami Y; Hiyama A; Hori K; Matsunaga N
    Clin Nucl Med; 2009 May; 34(5):314-5. PubMed ID: 19387215
    [No Abstract]   [Full Text] [Related]  

  • 20. AK000953 silencing can enhance the killing effect of danazol on uterine fibroids.
    Li S; Zhang Y; Niu L; Wang Q; Lu X; Zhao X; Liang J; Liu H
    Arch Gynecol Obstet; 2015 Nov; 292(5):1075-81. PubMed ID: 25894338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.